5035-09-6 Usage
Description
20α-Acetoxy-4-pregnen-3-one is a steroidal compound derived from the modification of the steroid hormone progesterone. It serves as an intermediate in the synthesis of other important steroidal compounds, such as testosterone and 4-pregnen-20β-ol-3-one.
Uses
Used in Pharmaceutical Industry:
20α-Acetoxy-4-pregnen-3-one is used as an intermediate in the synthesis of various steroidal drugs for the pharmaceutical industry. Its role in the production of testosterone (T155000) and 4-pregnen-20β-ol-3-one highlights its importance in the development of hormonal treatments and therapies.
Additionally, as an impurity of progesterone (P755900), 20α-Acetoxy-4-pregnen-3-one may be involved in the study and understanding of the side effects or interactions related to the use of progesterone in medical applications. This knowledge can contribute to the improvement of drug safety and efficacy.
Check Digit Verification of cas no
The CAS Registry Mumber 5035-09-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,0,3 and 5 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 5035-09:
(6*5)+(5*0)+(4*3)+(3*5)+(2*0)+(1*9)=66
66 % 10 = 6
So 5035-09-6 is a valid CAS Registry Number.
5035-09-6Relevant articles and documents
17β-aryl(arylmethyl)oxy(thio)alkyl-androstane derivatives
-
, (2008/06/13)
The invention relates to 17β-aryl(arylmethyl)oxy(thio)alkyl-androstane derivatives having general formula (I), wherein R1is (H,OR), (H,OSO3H) or NOR; with R being H, (C1-6)alkyl or (C1-6)acyl; each of R2and R3is independently hydrogen or (C1-6)alyl; n is 0, 1, or 2; X is O, S, S(O) or S(O)2; m is 0 or 1; each of R4, R5and R6is independently hydrogen, hydroxy, (C1-4)alkoxy, halogen, NR7R8or (C1-4)alkyl, optionally substituted by hydroxy, alkoxy, halogen or oxo; each of R7and R8is independently hydrogen or (C1-4)alkyl, and wherein the dotted lines indicate a Δ7or a Δ8double bond, or a pair of conjugated double bonds selected from Δ7,14, Δ8,14and Δ6,8(14); or a pharmaceutically acceptable salt thereof. The compounds of the invention have meiosis regulating activity and can be used for the control of fertility.
